Aptimmune Biologics Inc.
License fiscal year: 2015
Ohio State primary inventor(s): Renukaradhya Gourapura
College: Food, Agricultural, and Environmental Sciences
Department: Food Animal Health Research Program
Leadership: Heather Bessoff
Ownership status: Privately held
Headquarters: St. Louis, MO
Description: Aptimmune Biologics specializes in developing mucosal vaccines to protect against the most costly viral diseases affecting the swine industry. Its first vaccines are focused on addressing two major viral respiratory pathogens, Porcine Reproductive and Respiratory Virus (PRRSV) and Influenza A virus in swine (IAV-S).